Novo Nordisk A/S has cut the prices its weight-loss drug Wegovy by up to 37% in India, as the Danish drugmaker looks to hold its own against Eli Lilly & Co.’s Mounjaro in a country that’s home to the third largest obesity population in the world. Novo Nordisk will sell Poviztra 2.4 mg semaglutide injection […]
After Eli Lilly, Novo Nordisk has teamed up with an Indian partner to market its weight-loss drug under a new brand name in the world’s third most obese country. Novo Nordisk will sell Poviztra 2.4 mg semaglutide injection in India as a separate brand of its blockbuster weight-loss drug WeGovy. (Reuters) The Danish drugmaker will […]
